Utah Medical Products Dirección
Dirección controles de criterios 3/4
We currently do not have sufficient information about the CEO.
Información clave
Kevin Cornwell
Chief Executive Officer (CEO)
US$510.6k
Compensación total
| Porcentaje del salario del CEO | 29.8% |
| Permanencia del CEO | 31.4yrs |
| Participación del CEO | 5.3% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 27.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Utah Medical Products: An Attractive, But Speculative, Prospect
Mar 22Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Feb 09
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30
Dec 13Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30
Nov 23Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30
Nov 03Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295
Aug 28Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?
Mar 04Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295
Feb 10A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)
Jan 11Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29
Aug 08Utah Medical Products declares $0.29 dividend
Aug 02Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M
Jul 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
May 14Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29
Feb 26Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29
Feb 12Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital
Sep 28Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28
Aug 06Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation
May 01Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?
Mar 26Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
Mar 02Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 11Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain
Jan 27
Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?
Jan 13Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?
Dec 29Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?
Dec 15Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?
Nov 30Utah Medical Products declares $0.285 dividend
Nov 03Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$16m |
| Dec 31 2023 | US$511k | US$152k | US$17m |
| Sep 30 2023 | n/a | n/a | US$17m |
| Jun 30 2023 | n/a | n/a | US$17m |
| Mar 31 2023 | n/a | n/a | US$17m |
| Dec 31 2022 | US$452k | US$84k | US$16m |
| Sep 30 2022 | n/a | n/a | US$16m |
| Jun 30 2022 | n/a | n/a | US$16m |
| Mar 31 2022 | n/a | n/a | US$15m |
| Dec 31 2021 | US$494k | US$156k | US$15m |
| Sep 30 2021 | n/a | n/a | US$14m |
| Jun 30 2021 | n/a | n/a | US$13m |
| Mar 31 2021 | n/a | n/a | US$11m |
| Dec 31 2020 | US$327k | US$78k | US$11m |
| Sep 30 2020 | n/a | n/a | US$12m |
| Jun 30 2020 | n/a | n/a | US$13m |
| Mar 31 2020 | n/a | n/a | US$15m |
| Dec 31 2019 | US$474k | US$156k | US$15m |
| Sep 30 2019 | n/a | n/a | US$14m |
| Jun 30 2019 | n/a | n/a | US$17m |
| Mar 31 2019 | n/a | n/a | US$18m |
| Dec 31 2018 | US$501k | US$156k | US$19m |
| Sep 30 2018 | n/a | n/a | US$13m |
| Jun 30 2018 | n/a | n/a | US$10m |
| Mar 31 2018 | n/a | n/a | US$9m |
| Dec 31 2017 | US$501k | US$156k | US$9m |
Compensación vs. Mercado: La compensación total de Kevin($USD510.57K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD1.60M).
Compensación vs. Ingresos: Kevin's compensation has been consistent with company performance over the past year.
CEO
Kevin Cornwell (76 yo)
31.4yrs
Permanencia
US$510,570
Compensación
Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 31.3yrs | US$510.57k | 5.25% $ 12.7m | |
| Independent Director | 26.3yrs | US$29.40k | 0.60% $ 1.4m | |
| Independent Lead Director | 28.3yrs | US$37.80k | 0.14% $ 336.6k | |
| Independent Director | 27.3yrs | US$29.40k | 0.13% $ 325.7k | |
| Independent Director | 17.3yrs | US$29.40k | 0.37% $ 883.6k |
27.3yrs
Permanencia media
76yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de UTMD son experimentados ( 27.3 años antigüedad media).